Reviva Pharmaceuticals Holdings (RVPH) Income Statement: Revenue & Earnings

Reviva Pharmaceuticals Holdings Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Reviva Pharmaceuticals Holdings, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	22.91	31.42	22.87	4.85	0.30
Selling, General & Administrative	7.89	8.08	5.36	5.25	2.14
Operating Expenses	30.80	39.50	28.23	10.10	2.43
Operating Income	-30.80	-39.50	-28.23	-10.10	-2.43
Other Income/Expense
Interest Income	0.36	0.40	0.18	0.00	0.08
Interest Expense	-0.02	0.03	0.00	0.00	-1.45
Other Income/Expense	0.56	-0.10	-0.19	-1.59	-0.11
Income
Income Before Tax	-29.90	-39.24	-28.24	-8.52	-3.78
Income Tax Expense	0.02	0.02	0.02	0.01	0.00
Net Income	-29.92	-39.26	-28.26	-8.52	-3.78
Net Income - Continuous Operations	-29.92	-39.26	-28.26	-8.52	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-29.88	-39.21	-28.23	-8.51	-2.33
EBIT	-30.80	-39.21	-28.23	-8.51	-2.33
Depreciation & Amortization	30.80	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-1.00	-2.00	-1.00	-1.00	-1.00
Diluted EPS	-1.00	-2.00	-1.00	-1.00	-1.00
Basic Shares Outstanding	33.15	23.80	19.52	14.79	3.06
Diluted Shares Outstanding	33.15	23.80	19.52	14.79	3.06